On the public citation graph

Gut Microbiota and Non-Alcoholic Fatty Liver Disease Severity in Type 2 Diabetes Patients

https://doi.org/10.3390/jpm11030238
0 signed · 69 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/hep.28356openalex-snapshot
The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota
inferredcites →https://doi.org/10.1002/hep.31122openalex-snapshot
Letter to the Editor: Regional Epidemics of Nonalcoholic Fatty Liver Disease: Timing of Westernization and Ethnicity Matter
inferredcites →https://doi.org/10.1007/s11154-015-9309-0openalex-snapshot
The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity
inferredcites →https://doi.org/10.1007/s11427-017-9303-9openalex-snapshot
Characteristics of fecal microbiota in non-alcoholic fatty liver disease patients
inferredcites →https://doi.org/10.1007/s12263-011-0229-7openalex-snapshot
Intestinal microbiota in human health and disease: the impact of probiotics
inferredcites →https://doi.org/10.1016/j.cgh.2013.02.015openalex-snapshot
Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1016/j.jhep.2013.12.018openalex-snapshot
Controlled attenuation parameter (CAP) for the diagnosis of steatosis: A prospective study of 5323 examinations
inferredcites →https://doi.org/10.1016/j.jpeds.2012.08.043openalex-snapshot
Increasing Prevalence of Nonalcoholic Fatty Liver Disease Among United States Adolescents, 1988-1994 to 2007-2010
inferredcites →https://doi.org/10.1016/j.micpath.2017.07.034openalex-snapshot
The association of type II diabetes with gut microbiota composition
inferredcites →https://doi.org/10.1016/j.ultrasmedbio.2003.07.001openalex-snapshot
Transient elastography: a new noninvasive method for assessment of hepatic fibrosis
inferredcites →https://doi.org/10.1038/ijo.2015.84openalex-snapshot
The role of short chain fatty acids in appetite regulation and energy homeostasis
inferredcites →https://doi.org/10.1038/nature10809openalex-snapshot
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
inferredcites →https://doi.org/10.1038/nature11450openalex-snapshot
A metagenome-wide association study of gut microbiota in type 2 diabetes
inferredcites →https://doi.org/10.1038/nrendo.2017.173openalex-snapshot
Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus
inferredcites →https://doi.org/10.1038/nrgastro.2010.172openalex-snapshot
The role of the gut microbiota in nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1038/s41574-019-0156-zopenalex-snapshot
Gut microbial metabolites in obesity, NAFLD and T2DM
inferredcites →https://doi.org/10.1038/s41575-020-0269-9openalex-snapshot
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
inferredcites →https://doi.org/10.1053/j.gastro.2019.01.042openalex-snapshot
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1073/pnas.1219451110openalex-snapshot
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
inferredcites →https://doi.org/10.1111/j.1365-2036.2011.04724.xopenalex-snapshot
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
inferredcites →https://doi.org/10.1111/j.1467-789x.2010.00797.xopenalex-snapshot
Do nutrient–gut–microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?
inferredcites →https://doi.org/10.1111/liv.13643openalex-snapshot
Global epidemiology of non‐alcoholic fatty liver disease/non‐alcoholic steatohepatitis: What we need in the future
inferredcites →https://doi.org/10.1136/gut.2005.069153openalex-snapshot
Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study
inferredcites →https://doi.org/10.1136/gut.2010.221382openalex-snapshot
Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years
inferredcites →https://doi.org/10.1136/gutjnl-2012-303816openalex-snapshot
Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice
inferredcites →https://doi.org/10.1136/gutjnl-2012-303839openalex-snapshot
An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice
inferredcites →https://doi.org/10.1146/annurev-nutr-072610-145146openalex-snapshot
Interaction Between Obesity and the Gut Microbiota: Relevance in Nutrition
inferredcites →https://doi.org/10.1146/annurev-pathol-121808-102132openalex-snapshot
Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis
inferredcites →https://doi.org/10.1155/2018/9321643openalex-snapshot
Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1155/2018/9340316openalex-snapshot
The Association of Gut Microbiota with Nonalcoholic Steatohepatitis in Thais
inferredcites →https://doi.org/10.1186/s13073-016-0271-6openalex-snapshot
Sub-clinical detection of gut microbial biomarkers of obesity and type 2 diabetes
inferredcites →https://doi.org/10.1194/jlr.r036012openalex-snapshot
The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism
inferredcites →https://doi.org/10.1371/journal.pone.0009085openalex-snapshot
Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
inferredcites →https://doi.org/10.1371/journal.pone.0062885openalex-snapshot
Molecular Characterization of the Fecal Microbiota in Patients with Nonalcoholic Steatohepatitis – A Longitudinal Study
inferredcites →https://doi.org/10.1371/journal.ppat.1004559openalex-snapshot
Implication of Gut Microbiota in Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1530/eje-14-0874openalex-snapshot
MECHANISMS IN ENDOCRINOLOGY: Gut microbiota in patients with type 2 diabetes mellitus
inferredcites →https://doi.org/10.2337/dc10-2229openalex-snapshot
Prevalence of and Risk Factors for Hepatic Steatosis and Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: the Edinburgh Type 2 Diabetes Study
inferredcites →https://doi.org/10.3390/jcm9051369openalex-snapshot
A Role for Gut Microbiome Fermentative Pathways in Fatty Liver Disease Progression
inferredcites →https://doi.org/10.3390/nu11081712openalex-snapshot
Gut Microbiota-Derived Components and Metabolites in the Progression of Non-Alcoholic Fatty Liver Disease (NAFLD)
inferredcites →https://doi.org/10.3978/j.issn.2304-3881.2015.01.03openalex-snapshot
Fatty liver disease in diabetes mellitus.
inferredcites →https://doi.org/10.4291/wjgp.v6.i4.110openalex-snapshot
New-found link between microbiota and obesity
inferredcites →https://doi.org/10.7150/ijms.51164openalex-snapshot
The Association of Targeted Gut Microbiota with Body Composition in Type 2 Diabetes Mellitus

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4621344openalex-extracted
Characteristics Analysis and Intestinal Effects of Probiotic-Derived Nano-Selenium by Lactobacilllus Bulgaricus Cicc 20247
inferred← citeshttps://doi.org/10.1007/s11684-022-0960-zopenalex-snapshot
Role of Akkermansia muciniphila in the development of nonalcoholic fatty liver disease: current knowledge and perspectives
inferred← citeshttps://doi.org/10.1007/s44337-025-00489-1openalex-snapshot
Visiting MASLD through the lens of sex, immunity, and microbial interactions
inferred← citeshttps://doi.org/10.1016/j.aqrep.2024.102098openalex-snapshot
Supplementation with optimized multivitamin premix relieves liver steatosis by inhibiting CD36 palmitoylation and regulating intestinal microorganisms in largemouth bass (Micropterus salmoides)
inferred← citeshttps://doi.org/10.1016/j.fbio.2026.109870openalex-snapshot
Soyasaponin A1 ameliorates metabolic dysfunction-associated steatohepatitis via potentially reinforcing hepatoprotective capacity of Akkermansia muciniphila, restoring intestinal barrier homeostasis, and putatively modulating wnt/β-catenin signaling pathway
inferred← citeshttps://doi.org/10.1016/j.gastha.2021.10.008openalex-snapshot
Circadian Rhythms, the Gut Microbiome, and Metabolic Disorders
inferred← citeshttps://doi.org/10.1016/j.phymed.2025.157348openalex-snapshot
Yuzhuo Zhixiao pill can treat non-alcoholic steatohepatitis through modulation of gut microbiota, bile acid and short-chain fatty acid metabolism
inferred← citeshttps://doi.org/10.1021/acsfoodscitech.2c00240openalex-snapshot
Whole Eggs Improve High-Fat Diet-Induced Disorders of the Hepatic Lipid Profile and Gut Microbiota in Mice
inferred← citeshttps://doi.org/10.1021/acsfoodscitech.3c00138openalex-snapshot
Hypocholesterolemic Effect of Milks Fermented with Specific Strains of Lactococcus lactis in Hypercholesterolemic Sprague–Dawley Rats
inferred← citeshttps://doi.org/10.1080/00439339.2026.2642167openalex-snapshot
Pathogenesis of fatty liver haemorrhagic syndrome in laying hens and advances in nutritional intervention through feed additives
inferred← citeshttps://doi.org/10.1080/19490976.2026.2734705openalex-snapshot
Effects of Lactobacillus acidophilus on hepatic and microbial dysregulation in MASLD and diabetes
inferred← citeshttps://doi.org/10.1093/fqsafe/fyaf035openalex-snapshot
Cyanidin-3-O-glucoside alleviates non-alcoholic fatty liver disease through modulation of the gut microbiota
inferred← citeshttps://doi.org/10.1101/2023.05.19.540989openalex-snapshot
Longitudinal analysis of a dietary mouse model of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
inferred← citeshttps://doi.org/10.1111/obr.13646openalex-snapshot
Composition of gut microbiota and non‐alcoholic fatty liver disease: A systematic review and meta‐analysis
inferred← citeshttps://doi.org/10.1136/gutjnl-2023-330110openalex-snapshot
Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1155/2022/4752148openalex-snapshot
Bile Acids: A Bridge Linking Gut Microbiota and NAFLD
inferred← citeshttps://doi.org/10.1155/ijcp/8660821openalex-snapshot
A Comprehensive Review on the Therapeutic Effects of Salvia hispanica L. (Chia) on Metabolic Dysfunction–Associated Fatty Liver Disease: Special Focus on Pathogenesis
inferred← citeshttps://doi.org/10.1186/s13578-025-01525-4openalex-snapshot
Combination of GLP-1 receptor agonist and Akkermansia muciniphila Akk11 reduces adiposity and ameliorates MASLD in T2D mice
inferred← citeshttps://doi.org/10.12669/pjms.38.7.6289openalex-snapshot
Clinico-pathological features and related risk factors of Type-2 diabetes mellitus complicated with nonalcoholic fatty liver
inferred← citeshttps://doi.org/10.3389/fmed.2021.805029openalex-snapshot
Alterations in the Gut Microbiota and Hepatitis-B-Virus Infection in Southern Chinese Patients With Coexisting Non-Alcoholic Fatty Liver Disease and Type-2 Diabetes Mellitus
inferred← citeshttps://doi.org/10.3389/fmicb.2023.1093486openalex-snapshot
Construction of antibiotic-induced depression mice model and the function of intestinal microbiota
inferred← citeshttps://doi.org/10.3390/biomedicines11041097openalex-snapshot
Non-Alcoholic Fatty Liver Disease or Type 2 Diabetes Mellitus—The Chicken or the Egg Dilemma
inferred← citeshttps://doi.org/10.3390/jpm12040617openalex-snapshot
Interrelationship of Gut Microbiota, Obesity, Body Composition and Insulin Resistance in Asians with Type 2 Diabetes Mellitus
inferred← citeshttps://doi.org/10.3390/nu13082679openalex-snapshot
Gut Microbiota and Subclinical Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus
inferred← citeshttps://doi.org/10.3390/nu14214641openalex-snapshot
Interplay of Lymphocytes with the Intestinal Microbiota in Children with Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.36740/wlek202110212openalex-snapshot
INSULIN RESISTANCE AS AN INDICATOR OF DIFFERENTIATION FOR THE FORMATION OF RISK GROUPS FOR NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITHOUT TYPE 2 DIABETES MELLITUS, AS A PART OF ONTOLOGICAL MODEL OF NON-ALCOHOLIC FATTY LIVER DISEASE
inferred← citeshttps://doi.org/10.3980/j.issn.2222-3959.2011.01.24openalex-snapshot
Epidemiology and Rb1 gene of retinoblastoma.
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.